Mark Wolfson1, Jessica R Pockey2, Beth A Reboussin3, Erin L Sutfin4, Kathleen L Egan4, Kimberly G Wagoner4, John G Spangler5. 1. Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, United States. Electronic address: mwolfson@wakehealth.edu. 2. 12 Oak Leaf Lane, West Chester, PA 19382, United States. 3. Department of Biostatistical Sciences, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, United States. 4. Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, United States. 5. Department of Family and Community Medicine, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, United States.
Abstract
BACKGROUND: Dissolvable tobacco products (DTPs) have been introduced into test markets in the U.S. We sought to gauge the level of interest in trying these products and correlates of interest among potential consumers. METHODS: A web-based survey of freshman at 11 universities in North Carolina and Virginia was conducted in fall 2010. Multivariable logistic regression analyses were used to identify correlates of students' likelihood to try DTPs if offered a free sample. RESULTS: Weighted prevalence of likelihood to try DTPs was 3.7%. Significant correlates of likelihood to try included male gender, current cigarette smoking, current snus use, sensation seeking, lifetime illicit drug use, and perceived health risk of using DTPs. Among current smokers, current snus use, current use of chewing tobacco, and considering quitting smoking were associated with likelihood to try DTPs. CONCLUSIONS: While overall interest in trying these products was low, current users of cigarettes and snus were much more likely than others in trying a free sample. Some current smokers may consider DTPs to be an aid to smoking cessation, although the population-level impact of introducing these products is unknown.
BACKGROUND: Dissolvable tobacco products (DTPs) have been introduced into test markets in the U.S. We sought to gauge the level of interest in trying these products and correlates of interest among potential consumers. METHODS: A web-based survey of freshman at 11 universities in North Carolina and Virginia was conducted in fall 2010. Multivariable logistic regression analyses were used to identify correlates of students' likelihood to try DTPs if offered a free sample. RESULTS: Weighted prevalence of likelihood to try DTPs was 3.7%. Significant correlates of likelihood to try included male gender, current cigarette smoking, current snus use, sensation seeking, lifetime illicit drug use, and perceived health risk of using DTPs. Among current smokers, current snus use, current use of chewing tobacco, and considering quitting smoking were associated with likelihood to try DTPs. CONCLUSIONS: While overall interest in trying these products was low, current users of cigarettes and snus were much more likely than others in trying a free sample. Some current smokers may consider DTPs to be an aid to smoking cessation, although the population-level impact of introducing these products is unknown.
Authors: Micaela H Coady; Christina A Chan; Kari Auer; Shannon M Farley; Elizabeth A Kilgore; Susan M Kansagra Journal: Tob Control Date: 2012-06-23 Impact factor: 7.552
Authors: Mariann R Piano; Neal L Benowitz; Garret A Fitzgerald; Susan Corbridge; Janie Heath; Ellen Hahn; Terry F Pechacek; George Howard Journal: Circulation Date: 2010-09-13 Impact factor: 29.690
Authors: Lin Li; Ron Borland; Hua-Hie Yong; Sara C Hitchman; Melanie A Wakefield; Karin A Kasza; Geoffrey T Fong Journal: Addiction Date: 2012-02 Impact factor: 6.526
Authors: Alexandra Loukas; Milena D Batanova; Cayley E Velazquez; Whitney J Lang; Gail G Sneden; Keryn E Pasch; Shelley Summers Karn; Trina R Robertson Journal: Nicotine Tob Res Date: 2011-09-08 Impact factor: 4.244
Authors: Gregory N Connolly; Patricia Richter; Alfred Aleguas; Terry F Pechacek; Stephen B Stanfill; Hillel R Alpert Journal: Pediatrics Date: 2010-04-19 Impact factor: 7.124
Authors: Cynthia K Suerken; Beth A Reboussin; Erin L Sutfin; Kimberly G Wagoner; John Spangler; Mark Wolfson Journal: Addict Behav Date: 2014-01 Impact factor: 3.913
Authors: Erin L Sutfin; Beth A Reboussin; Beata Debinski; Kimberly G Wagoner; John Spangler; Mark Wolfson Journal: Am J Public Health Date: 2015-06-11 Impact factor: 9.308
Authors: Kathleen L Egan; Cynthia K Suerken; Beth A Reboussin; John Spangler; Kimberly G Wagoner; Erin L Sutfin; Beata Debinski; Mark Wolfson Journal: Am J Drug Alcohol Abuse Date: 2015-06-01 Impact factor: 3.829
Authors: Kimberly G Wagoner; Eunyoung Y Song; Kathleen L Egan; Erin L Sutfin; Beth A Reboussin; John Spangler; Mark Wolfson Journal: Nicotine Tob Res Date: 2014-05-20 Impact factor: 4.244
Authors: Kimberly G Wagoner; Micah Berman; Shyanika W Rose; Eunyoung Song; Jennifer Cornacchione Ross; Elizabeth G Klein; Dannielle E Kelley; Jessica L King; Mark Wolfson; Erin L Sutfin Journal: Tob Control Date: 2019-05-23 Impact factor: 7.552
Authors: Mark Wolfson; Cynthia K Suerken; Kathleen L Egan; Erin L Sutfin; Beth A Reboussin; Kimberly G Wagoner; John Spangler Journal: Am J Drug Alcohol Abuse Date: 2015-09-16 Impact factor: 3.829
Authors: Jessica L King; Kimberly G Wagoner; Cynthia K Suerken; Eunyoung Y Song; Beth A Reboussin; John Spangler; Stephannie Walker; Jennifer Cornacchione Ross; Mark Wolfson; Erin L Sutfin Journal: Subst Use Misuse Date: 2020-09-24 Impact factor: 2.164
Authors: Cynthia K Suerken; Beth A Reboussin; Kathleen L Egan; Erin L Sutfin; Kimberly G Wagoner; John Spangler; Mark Wolfson Journal: Drug Alcohol Depend Date: 2016-03-19 Impact factor: 4.492
Authors: Erin L Sutfin; Alicia Sparks; Jessica R Pockey; Cynthia K Suerken; Beth A Reboussin; Kimberly G Wagoner; John Spangler; Mark Wolfson Journal: Addict Behav Date: 2015-07-26 Impact factor: 3.913